Anavex Life Sciences Corp (AVXL)

[sokol]

If the old saying "volume leads price" has merit, the share price is definitely up for the most part. Look at the volume for the last few days. Volume has significantly increased. Share price may take a breather soon, but I would not be discouraged. I think it is likely the trend will now be our friend. The trend was down for approximately 7 months from October 2017 (when SP was above $5.00) through May 2018, but it has clearly turned upward. In the last 4 days share price has moved above the 200 MA line and held at and above that line. Price could briefly pull back below the 200 day MA. However, AVXL has recently gained some positive analyst ratings, the passage of the right to try law sends a positive message, important CNS conferences will be taking place soon, and announcements about clinical trials will occur. Therefore, the odds are favorable for seeing AVXL in the $5.00 range again in the near term.